Skip to content
2000
image of Association of Toll-like Receptor 4 Gene Polymorphisms with Diabetes Type 2 Patients in the Palestinian Population

Abstract

Background

Toll-like Receptor 4 (TLR4) plays critical roles in innate immunity and several other pathological responses, including a possible role in the susceptibility to Type 2 Diabetes Mellitus (T2DM). Understanding the relationship between TLR4 polymorphism and T2DM is necessary to evaluate the role of innate immunity in diabetes.

Aim

This study was conducted to evaluate the potential association between three TLR4 SNPs (SNP ID rs11536858, rs4986790, and rs1927914) and risk susceptibility to T2DM in a cross-section of the Palestinian population.

Methods

A total of 96 individuals including 50 T2DM patients participated in this study. The data were analyzed according to the TLR4 allelic variation results. DNAs were extracted from blood samples collected from the T2DM patients and their matched healthy controls and used to evaluate possible associations between the TLR4 SNP variations and T2DM. The genotypes of TLR4 polymorphisms were analyzed by the Polymerase Chain Reaction-Restriction Fragment Length Polymorphism (PCR-RFLP).

Results

Three allelic variations were detected in the participating individuals. The distribution of alleles between T2DM and healthy controls in the three SNPs did not show significant differences, even though some variations tended to favor certain alleles. To look at potential associations of TLR4 gene polymorphisms with the risk of T2DM development, we analyzed the allelic variation in both T2DM patients and health controls. The rs4986790 TLR4 SNPs showed a significant association with T2DM. There were 20% heterozygous alleles in T2DM patients compared to 4.35% in healthy controls with Odds Ratio (OR) = 5.26 and 95% CI = 1.08, 25.6 ( = 0.0252), indicating the AG allele to be a risk factor. Both rs11536858 and rs1927914 alleles demonstrated a potential association of their allelic variations as either a protective or a high-risk factor.

Conclusion

Our data have indicated that TLR4 rs4986790, rs1927914, and rs11536858 may play a potential role in innate immunity and susceptibility risk to diabetes and can be potential targets for therapeutic drugs.

Loading

Article metrics loading...

/content/journals/emiddt/10.2174/0118715303301789240826113528
2025-01-03
2025-05-28
Loading full text...

Full text loading...

References

  1. World Health Organization 2022 Available from: https://www.who.int/news-room/fact-sheets/detail/diabetes
  2. Palestinian National Diabetes Program-WDF15-1304-World Diabetes Foundation
  3. Available from: https://www.worlddiabetesfoundation.org/projects/west-bank-and-gaza-wdf15-1304
  4. Aghamiri S.H. Komlakh K. Ghaffari M. Toll-Like Receptors (TLRs) and their potential therapeutic applications in diabetic neuropathy. Int. Immunopharmacol. 2022 102 108398 10.1016/j.intimp.2021.108398 34863652
    [Google Scholar]
  5. McKernan D.P. Toll-Like Receptors as Drug Targets in the Intestinal Epithelium. Handb. Exp. Pharmacol. 2021 276 291 314 10.1007/164_2021_563 34783909
    [Google Scholar]
  6. Ren W. Zhao L. Sun Y. Wang X. Shi X. HMGB1 and Toll-like receptors: potential therapeutic targets in autoimmune diseases. Mol. Med. 2023 29 1 117 10.1186/s10020‑023‑00717‑3 37667233
    [Google Scholar]
  7. Kawai T. Akira S. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. Immunity 2011 34 5 637 650 10.1016/j.immuni.2011.05.006 21616434
    [Google Scholar]
  8. Zhang Y. Liu J. Wang C. Liu J. Lu W. Toll-Like Receptors Gene Polymorphisms in Autoimmune Disease. Front. Immunol. 2021 12 672346 10.3389/fimmu.2021.672346 33981318
    [Google Scholar]
  9. Bzówka M. Bagrowska W. Góra A. Recent Advances in Studying Toll-like Receptors with the Use of Computational Methods. J. Chem. Inf. Model. 2023 63 12 3669 3687 10.1021/acs.jcim.3c00419 37285179
    [Google Scholar]
  10. Lannoy V. Côté-Biron A. Asselin C. Rivard N. TIRAP, TRAM, and Toll-Like Receptors: The Untold Story. Mediators Inflamm. 2023 2023 1 13 10.1155/2023/2899271 36926280
    [Google Scholar]
  11. Wong F.S. Wen L. Toll-like receptors and diabetes. Ann. N. Y. Acad. Sci. 2008 1150 1 123 132 10.1196/annals.1447.063 19120280
    [Google Scholar]
  12. Florez J.C. Miriam S. Udler M.S. Hanson R.L. Cowie C.C. Casagrande S.S. Menke A. Genetics of Type 2 Diabetes. Diabetes in America. 3rd ed Bethesda, MD National Institute of Diabetes and Digestive and Kidney Diseases (US) 2018
    [Google Scholar]
  13. Khanmohammadi S. Kuchay M.S. Toll-like receptors and metabolic (dysfunction)-associated fatty liver disease. Pharmacol. Res. 2022 185 106507 10.1016/j.phrs.2022.106507 36252773
    [Google Scholar]
  14. Lee N. Ko R. Lee S.Y. Differential Expression Patterns of Toll-like Receptors in COVID-19 Patients. Frontiers in Bioscience-Landmark 2023 28 11 307 10.31083/j.fbl2811307 38062845
    [Google Scholar]
  15. Li F. Song B. Zhou W.F. Chu L.J. Toll-Like Receptors 7/8: A Paradigm for the Manipulation of Immunologic Reactions for Immunotherapy. Viral Immunol. 2023 36 9 564 578 10.1089/vim.2023.0077 37751284
    [Google Scholar]
  16. Tang X. Xu Q. Yang S. Huang X. Wang L. Huang F. Luo J. Zhou X. Wu A. Mei Q. Zhao C. Wu J. Toll-like Receptors and Thrombopoiesis. Int. J. Mol. Sci. 2023 24 2 1010 10.3390/ijms24021010 36674552
    [Google Scholar]
  17. Zhang Z. Liu Z. Lv A. Fan C. How Toll-like receptors influence Parkinson’s disease in the microbiome–gut–brain axis. Front. Immunol. 2023 14 1154626 10.3389/fimmu.2023.1154626 37207228
    [Google Scholar]
  18. Fan J. Liang R. Quantitative assessment of TLR4 gene polymorphisms and T2DM risk: A meta‐analysis. Mol. Genet. Genomic Med. 2020 8 10 e1466 10.1002/mgg3.1466 32822111
    [Google Scholar]
  19. Jiang Z.S. Wang S.X. Jia H.X. Wang J. Liu Y.T. Association of toll-like receptor 4 polymorphisms with type 2 diabetes mellitus. Inflammation 2013 36 1 251 257 10.1007/s10753‑012‑9541‑7 22956123
    [Google Scholar]
  20. Fu X.D. Sun X.Q. Wang H.Y. Guo J.F. Zhang G.Z. Xu Q.H. Genetic polymorphisms of the TLR4 gene and their association with susceptibility to type 2 diabetes mellitus in the Chinese population. Genet. Mol. Res. 2013 12 3 3813 3820 10.4238/2013.September.19.13 24085443
    [Google Scholar]
  21. Cai H. Cai J. Tao G. Association of toll‐like receptor 4 polymorphisms with type 2 diabetes mellitus. Acta Pathol. Microbiol. Scand. Suppl. 2013 121 7 605 611 10.1111/apm.12027 23163570
    [Google Scholar]
  22. Lei T. Tang W. Xiong Y. Di Y. Zhang K. Shu X. Association of TLR4 gene polymorphisms with susceptibility to type 2 diabetes mellitus in the Chinese Han population. Int. Immunopharmacol. 2015 24 1 68 71 10.1016/j.intimp.2014.11.007 25479716
    [Google Scholar]
  23. Buraczynska M. Zukowski P. Ksiazek K. Wacinski P. Dragan M. The effect of Toll-like receptor 4 gene polymorphism on vascular complications in type 2 diabetes patients. Diabetes Res. Clin. Pract. 2016 116 7 13 10.1016/j.diabres.2016.04.002 27321310
    [Google Scholar]
  24. Doody N.E. Dowejko M.M. Akam E.C. Cox N.J. Bhatti J.S. Singh P. Mastana S.S. The role of TLR4, TNF-alphs and IL-1beta in type 2 diabetes mellitus development within a North Indian polulation. Ann. Hum. Genet. 2017 81 4 141 146 10.1111/ahg.12197 28620993
    [Google Scholar]
  25. Ferwerda B. McCall M.B.B. Alonso S. Giamarellos-Bourboulis E.J. Mouktaroudi M. Izagirre N. Syafruddin D. Kibiki G. Cristea T. Hijmans A. Hamann L. Israel S. ElGhazali G. Troye-Blomberg M. Kumpf O. Maiga B. Dolo A. Doumbo O. Hermsen C.C. Stalenhoef A.F.H. van Crevel R. Brunner H.G. Oh D.Y. Schumann R.R. de la Rúa C. Sauerwein R. Kullberg B.J. van der Ven A.J.A.M. van der Meer J.W.M. Netea M.G. TLR4 polymorphisms, infectious diseases, and evolutionary pressure during migration of modern humans. Proc. Natl. Acad. Sci. USA 2007 104 42 16645 16650 10.1073/pnas.0704828104 17925445
    [Google Scholar]
  26. Džumhur A. Zibar L. Wagner J. Šimundić T. Dembić Z. Barbić J. Association studies of gene polymorphisms in toll-like receptors 2 and 4 in Croatian patients with acute myocardial infarction. Scand. J. Immunol. 2012 75 5 517 523 10.1111/j.1365‑3083.2012.02681.x 22229967
    [Google Scholar]
  27. Huang W.H. Nie L.H. Zhang L.J. Jing L.P. Dong F. Wang M. Zhang N. Liu Y. Zhang B.H. Chen C. Lin H.S. Wei X.C. Yang G. Jing C.X. Association of TLR2 and TLR4 non-missense single nucleotide polymorphisms with type 2 diabetes risk in a southern Chinese population: a case-control study. Genet. Mol. Res. 2015 14 3 8694 8705 10.4238/2015.July.31.18 26345801
    [Google Scholar]
  28. Peng D. Jiang F. Zhang R. Tang S. Chen M. Yan J. Sun X. Luo Y. Hu C. Jia W. Association of Toll-like Receptor 4 Gene polymorphisms with susceptibility to type 2 diabetes mellitus in the Chinese population. J. Diabetes 2015 7 4 485 492 10.1111/1753‑0407.12206 25104099
    [Google Scholar]
  29. Xu Y. Jiang Z. Huang J. Meng Q. Coh P. Tao L. The association between toll-like receptor 4 polymorphisms and diabetic retinopathy in Chinese patients with type 2 diabetes. Br. J. Ophthalmol. 2015 99 9 1301 1305 10.1136/bjophthalmol‑2015‑306677 25947554
    [Google Scholar]
  30. Gond D.P. Singh S. Agrawal N.K. Testing an association between TLR4 and CXCR1 gene polymorphisms with susceptibility to urinary tract infection in type 2 diabetes in north Indian population. Gene 2018 641 196 202 10.1016/j.gene.2017.10.060 29066305
    [Google Scholar]
  31. Aioanei C. Ilies R.F. Bala C. Petrisor M.F. Porojan M.D. Popp R.A. Catana A. The role of adiponectin and toll-like receptor 4 gene polymorphisms on non-proliferative retinopathy in type 2 diabetes mellitus patients. A case-control study in Romanian Caucasians patients. Acta Endocrinol 2019 15 1 32 38 10.4183/aeb.2019.32 31149057
    [Google Scholar]
  32. Permutt M.A. Wasson J. Cox N. Genetic epidemiology of diabetes. J. Clin. Invest. 2005 115 6 1431 1439 10.1172/JCI24758 15931378
    [Google Scholar]
  33. Freeman H. Cox R.D. Type-2 diabetes: a cocktail of genetic discovery. Hum. Mol. Genet. 2006 15 Review Issue 2 R202 R209 10.1093/hmg/ddl191 16987885
    [Google Scholar]
  34. Zheng Y. Ley S.H. Hu F.B. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat. Rev. Endocrinol. 2018 14 2 88 98 10.1038/nrendo.2017.151 29219149
    [Google Scholar]
  35. El Sharif N. Imam A. Current Status of Diabetes in Palestine: Epidemiology. Management, and Healthcare System. Handbook of Healthcare in the Arab World 2021 1053 1081
    [Google Scholar]
  36. Singh K. Singh V.K. Agrawal N.K. Gupta S.K. Singh K. Association of Toll-like receptor 4 polymorphisms with diabetic foot ulcers and application of artificial neural network in DFU risk assessment in type 2 diabetes patients. BioMed Res. Int. 2013 2013 1 9 10.1155/2013/318686 23936790
    [Google Scholar]
  37. Kanczkowski W. Ziegler C.G. Zacharowski K. Bornstein S.R. Toll-like receptors in endocrine disease and diabetes. Neuroimmunomodulation 2008 15 1 54 60 10.1159/000135624 18667800
    [Google Scholar]
  38. Zipris D. Toll-like receptors and type 1 diabetes. Adv. Exp. Med. Biol. 2010 654 585 610 10.1007/978‑90‑481‑3271‑3_25 20217515
    [Google Scholar]
  39. Dasu M.R. Ramirez S. Isseroff R.R. Toll-like receptors and diabetes: a therapeutic perspective. Clin. Sci. (Lond.) 2012 122 5 203 214 10.1042/CS20110357 22070434
    [Google Scholar]
  40. Rosa Ramirez S. Ravi Krishna Dasu M. Toll-like receptors and diabetes complications: recent advances. Curr. Diabetes Rev. 2012 8 6 480 488 10.2174/157339912803529887 22934553
    [Google Scholar]
  41. Gaulton K.J. Mechanisms of type 2 diabetes risk loci. Curr. Diab. Rep. 2017 17 9 72 10.1007/s11892‑017‑0908‑x 28741265
    [Google Scholar]
  42. Chen L. Guo S. Ranzer M.J. DiPietro L.A. Toll-like receptor 4 has an essential role in early skin wound healing. J. Invest. Dermatol. 2013 133 1 258 267 10.1038/jid.2012.267 22951730
    [Google Scholar]
  43. Brand S. Konrad A. Crispin A. Göke B. Lohse P. Ochsenkühn T. Seiderer J. Tillack C. Konrad A. Crispin A. Göke B. Lohse P. Ochsenkühn T. The role of Toll-like receptor 4 Asp299Gly and Thr399Ile polymorphisms and CARD15/NOD2 mutations in the susceptibility and phenotype of Crohn’s disease. Inflamm. Bowel Dis. 2005 11 7 645 652 10.1097/01.MIB.0000168372.94907.d2 15973118
    [Google Scholar]
  44. Hold G.L. Rabkin C.S. Chow W.H. Smith M.G. Gammon M.D. Risch H.A. Vaughan T.L. McColl K.E.L. Lissowska J. Zatonski W. Schoenberg J.B. Blot W.J. Mowat N.A.G. Fraumeni J.F. Jr El-Omar E.M. A functional polymorphism of toll-like receptor 4 gene increases risk of gastric carcinoma and its precursors. Gastroenterology 2007 132 3 905 912 10.1053/j.gastro.2006.12.026 17324405
    [Google Scholar]
  45. Rudofsky G. Jr Reismann P. Witte S. Humpert P.M. Isermann B. Chavakis T. Tafel J. Nosikov V.V. Hamann A. Nawroth P. Bierhaus A. Asp299Gly and Thr399Ile genotypes of the TLR4 gene are associated with a reduced prevalence of diabetic neuropathy in patients with type 2 diabetes. Diabetes Care 2004 27 1 179 183 10.2337/diacare.27.1.179 14693986
    [Google Scholar]
  46. Abdelsalam M. Allam S.H. Zohdy M. Magdy H. Mostafa M. TLR4 gene polymorphisms in Egyptian vitiligo patients: insights into emerging association with clinical activity, family history, and response to therapy. J. Genet. Eng. Biotechnol. 2021 19 1 132 145 10.1186/s43141‑021‑00218‑y 34468896
    [Google Scholar]
  47. Kim J.J. Sears D.D. TLR4 and Insulin Resistance. Gastroenterol. Res. Pract. 2010 2010 1 11 10.1155/2010/212563 20814545
    [Google Scholar]
/content/journals/emiddt/10.2174/0118715303301789240826113528
Loading
/content/journals/emiddt/10.2174/0118715303301789240826113528
Loading

Data & Media loading...


  • Article Type:
    Research Article
Keywords: Toll-like receptor 4 ; innate immune system ; type 2 diabetes
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test